Endometriosis Research Today is a free monthly online journal that collates and summarizes the latest research about Endometriosis, including details on causes, treatment, symptoms, infertility.

The levonorgestrel-releasing intrauterine device reduces CA-125 serum levels in patients with endometriosis.

de Sá Rosa e Silva AC, Rosa e Silva JC, Nogueira AA, Petta CA, Abrão MS, Ferriani RA

Department of Obstetrics and Gynecology, School of Medicine of Ribeirão Preto, University of São Paulo, Ribeirão Preto, Brazil. anasars@convex.com.br

This study compared the long-term effects of the levonorgestrel-releasing intrauterine device with those of GnRH agonist administration on serum levels of CA-125 in patients with endometriosis. The levonorgestrel-releasing intrauterine device was found to be as efficient as GnRH agonist in reducing CA-125 serum levels.

Published 5 September 2006 in Fertil Steril, 86(3): 742-4.
Full-text of this article is available online (may require subscription).

© 2004-2008 Endometriosis Research Today. All Rights Reserved.